Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice

Oncogene. 2004 Jun 24;23(29):5041-8. doi: 10.1038/sj.onc.1207688.

Abstract

The matrix metalloproteinase (MMP) family (approximately 25 members in mammals) has been implicated in extracellular matrix remodeling associated with embryonic development, cancer formation and progression, and various other physiological and pathological events. Inactivating mutations in individual matrix metalloproteinase genes in mice described so far, however, are nonlethal at least up to the first few weeks after birth, suggesting functional redundancy among MMP family members. Here, we report that mice lacking two MMPs, MMP-2 (nonmembrane type) and MT1-MMP (membrane type), die immediately after birth with respiratory failure, abnormal blood vessels, and immature muscle fibers reminiscent of central core disease. In the absence of MMP-2 and MT1-MMP, myoblast fusion in vitro is also significantly retarded. These findings suggest functional overlap in mice between the two MMPs with distinct molecular natures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Vessels / embryology*
  • Blood Vessels / pathology*
  • Genes, Lethal*
  • Matrix Metalloproteinase 14
  • Matrix Metalloproteinase 2 / genetics*
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases / genetics*
  • Mice
  • Mice, Mutant Strains
  • Muscle, Skeletal / embryology*
  • Muscle, Skeletal / pathology
  • Mutation
  • Myoblasts / pathology
  • Neovascularization, Pathologic

Substances

  • Mmp14 protein, mouse
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 14